- Investing Ideas
- Danish Pharmaceuticals & Biotech High Insider Buying
Danish Pharmaceuticals & Biotech High Insider Buying
Results
2
0 new
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
2 companies
H. Lundbeck
Market Cap: DKK 39.1b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 40.40
7D
2.4%
1Y
2.3%
Gubra
Market Cap: DKK 6.1b
A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.
GUBRA
DKK 361.80
7D
-7.8%
1Y
-43.6%